It is based on a naturally occurring peptide from the pineal gland, a neuroendocrine organ involved in circadian rhythm and hormone regulation
The therapy uses a very small, fine needle, similar to what's used for insulin, and the injection goes just under the skin into fatty tissue
10.1073/pnas.1424495112 45 JonesD
Total semaglutide used during this phase: 6.8 mg (4 injections of 1.7 mg) Cumulative total through week 16: 13.8 mg You are now into your second 10mg vial
In the Phase 3 REDEFINE 1 trial, cagrilintide monotherapy achieved 11.8% average weight loss over 68 weekscomparable to semaglutide but with a notably lower incidence of nausea and vomiting, making it a potential option for patients who dont tolerate GLP-1 medications well
Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: the SCALE insulin randomized controlled trial